Physician
Cardiology
Dr. Paul A. Overlie, MD
|
|
Give Review
Paul A. Overlie practices Cardiology. He went to medical school at University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is one of the top medical schools in the US. University of Colorado Denver School of Medicine is ranked 35/8 in Research/PrimaryCare. He has 1 awards "Fellow (FACC)". Paul Overlie is also a published MD. He has 37 paper published. The most recent paper is: Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot... Doctor Paul A. Overlie, MD is registered with Medicare and accepts Medicare payments.
Publications
- A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in Coronary arte...
- Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials.
- A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native Coronary lesions 12-month outcomes from t...
- Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo Coronary lesions: 2-year...
- Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with corona...
- Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting Coronary stents.
- First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic Coronary arteries: 6-month clinical a...
- Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.
- Long-term survival with use of percutaneous extracorporeal life support in patients presenting with Acute myocardial infarction and cardiovascular collapse.
- Clinical and angiographic follow-Up after primary stenting in Acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial.
- Long-term outcome after primary angioplasty: report from the primary angioplasty in Myocardial infarction (PAMI-I) trial.
- Stents in Acute myocardial infarction.
- Prospective, multicenter study of the safety and feasibility of primary stenting in Acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot...
- Excimer laser Coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experience.
- Stent placement compared with balloon angioplasty for obstructed Coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.
- Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAM...
- Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminog...
- Influence of Acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminoge...
- Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz St...
- Implications of recurrent ischemia after reperfusion therapy in Acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.
- Regional flow adjusted hemoperfusion during Coronary angioplasty: circulatory support/myocardial protection.
- Emergency use of cardioPulmonary bypass.
- Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for Acute myocardial infarction.
- Predictors of in-hospital and 6-month outcome after Acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail.
- Initiation and operation of a primary PTCA program.
- Technical aspects in the performance of primary PTCA.
- Emergency cardioPulmonary support with circulatory support devices.
- A comparison of immediate angioplasty with thrombolytic therapy for Acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
- Prophylactic versus standby cardiopulmonary support for high risk percutaneous transluminal Coronary angioplasty.
- Outcome of urgent percutaneous transluminal coronary angioplasty in Acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease.
- Emergency use of portable cardioPulmonary bypass.
- Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty.
- Improved patient survival after cardiac arrest using a cardioPulmonary support system.
- The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
- Cardiac complications of Wegener granulomatosis: a case report of complete Heart block and review of the literature.
- Refractory ergonovine-induced Coronary vasospasm: importance of intraCoronary nitroglycerin.
Schools
University Of Colorado School Of Medicine
University Colo Med Center
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
University of Colorado -
University of Colorado Denver School of Medicine
Drug Facts
| NPI NUMBER | 1598769275 | |
| NPPES Provider LastName | OVERLIE | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 794101220 | |
| NPPES Provider State | TX | |
| Specialty Description | Cardiology | |
| Total Claim Count | 8932.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 77.0 | |
| Percent Opioid Claims | 0.86 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598769275 |
| Last Name Of The Provider | OVERLIE |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Roberto E. Solis Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Paul D. Walter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James B. Moss III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aliakbar Arvandi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason B. Wischmeyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alejandro P. Perez-Verdia, MD |
|
Dr. Marc J. Levine, MD |
|
|
Dr. Alexander Trujillo, MD |
|
|
Dr. Walter C. Brogan III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Teerapat Nantsupawat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashwani Kumar, MD |
|
|
Dr. Sharmila Sehli, MD
This Doctor is OpenDoctor Recommended.
|